In vivo studies with the novel anticancer agent mitozolomide (NSC 353451) on Lewis lung carcinoma
- 1 March 1986
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 16 (2) , 125-128
- https://doi.org/10.1007/bf00256161
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Antitumour imidazotetrazinesJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Antitumour imidazotetrazines—IVBiochemical Pharmacology, 1984
- Antitumour imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one, a novel broad-spectrum antitumor agentJournal of Medicinal Chemistry, 1984
- DNA CROSS-LINKING AND CYTO-TOXICITY IN NORMAL AND TRANSFORMED HUMAN-CELLS TREATED INVITRO WITH 8-CARBAMOYL-3-(2-CHLOROETHYL)IMIDAZO[5,1-D]-1,2,3,5-TETRAZIN-4(3H)-ONE1984
- EFFECTS OF THE ANTITUMOR AGENT 8-CARBAMOYL-3-(2-CHLOROETHYL)IMIDAZO[5,1-D]-1,2,3,5-TETRAZIN-4(3H)-ONEON THE DNA OF MOUSE L1210 CELLS1984
- Flow-cytometric analysis of DNA distribution after VP16-213 treatment of Lewis lung carcinomaCancer Chemotherapy and Pharmacology, 1983
- DNA cross-linking and monoadduct repair in nitrosourea-treated human tumour cellsNature, 1980
- Reactions of 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in aqueous solutionJournal of Medicinal Chemistry, 1979